Ambarella and Epizyme: breaking out or breaking bad?

The market-neutral spread of AMBA/EPZM broke out on Thursday (02/04/2015), in generally choppy trading conditions, showing clear signs of continuing its upward trend.

Up 4.67% for the day and closing near the high of its daily range, AMBA/EPZM shows good signs of posting sizeable gains over the coming months.

Ambarella             is a semi-conductor stock that mainly serves the security and surveillance market and has seen a 162% increase in EPS             since last quarter and a 62% increase sales over the same time period. It also has an annual ROE of just under 33% showing that management are making good use of their capital.

In comparison, Epizyme is a biomed/biotech stock that is bucking the strong sector performance trend by returning a decrease in EPS             of -185% since last quarter and -72% in sales over the same time period. EPZM is definitely a laggard in a leading sector.

Anthony Walters 05/04/2015
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
SV Svenska
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
AR العربية
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out